5 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Frown Lines: new trials by email Literature Review of Frown Lines trials Research Report on Frown Lines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines Botulinum toxin A "BoNT/A-DP", Botulinum toxin A "Botox Cosmetics" - Frown Lines | Phase 2 | Completed | Croma-Pharma GmbH | 208 | 2020-06-24 | 2025-03-18 |
| Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) DaxibotulinumtoxinA for injection - Frown Lines | Phase 2 | Completed | Revance Therapeutics, Inc. | 61 | 2019-01-24 | 2023-02-16 |
| BOTOX® in the Treatment of Upper Facial Lines in Japan botulinum toxin Type A (44U), botulinum toxin Type A (32U) - Upper Facial Rhytides, Crow's Feet Lines | Phase 3 | Completed | Allergan | 101 | 2013-02-01 | 2015-02-10 |
| A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device Treatment with CryoTouch IV - Frown Lines, Glabellar Frown Lines | Completed | Pacira Pharmaceuticals, Inc | 61 | 2013-01-01 | 2015-03-24 | |
| Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device Treatment with CryoTouch III Device - Frown Lines, Glabellar Frown Lines | Completed | Pacira Pharmaceuticals, Inc | 17 | 2012-11-01 | 2015-03-24 |
Botulinum Toxins, Type A (2) · Therapeutics (2) · Injections (1)
Pacira Pharmaceuticals, Inc (2) · Allergan (1) · Croma-Pharma GmbH (1) · Revance Therapeutics, Inc. (1)
United States (4) · Canada (2) · Austria (1) · Japan (1)
Larry Fan, MD (1) · Larry K Fan, MD (1)